Auriga

Auriga has upgraded Collective Brands (NYSE: PSS) from Hold to Buy and has established a $20 price target.

Auriga has downgraded Trina Solar (NYSE: TSL) from Hold to Sell and has lowered the price target from $8 to $3.50.

Auriga has published a research on Spectrum Pharmaceuticals (NASDAQ: SPPI) and has raised the price target on on the company to $15. In the report, Auriga writes, "Spectrum Pharmaceuticals receives the FDA's approval for the removal of the bioscan requirement of Zevalin. It not only simplifies the...

A report from Auriga reiterates its Buy rating and $55 price target on DSW (NYSE: DSW). The report states, “We noted solid traffic and sell through during Q3. A recent clearance event just started in stores and online ahead of Black Friday. Casuals, flats and pumps were included in the clearance,...

A report from Auriga reiterates its Buy rating and lowers its price target from $15 to $14 on MedAssets (NASDAQ: MDAS). The report states, “We are reiterating our BUY rating on MedAssets (MDAS) following a day on the road of management meetings. First off, given the rich price paid for Broadlane...

A report from Auriga reiterates its Buy rating and raises its price target from $65 to $68 on Haynes International (NASDAQ: HAYN). The report states, “Haynes International (HAYN) reported fiscal 4Q EPS results of $0.92 versus our estimate of $0.81 and consensus of $0.81. This compares to $0.75...

Auriga has lowered the price target on MedAssets (NASDAQ: MDAS) from $15 to $14 and maintains its Buy rating.

In a published report, Auriga reiterates its Buy rating and $17 price target on Marvell Technology Group Ltd. (NASDAQ: MRVL) following an in-line quarter despite headwinds due to flood impact. According to Auriga, “MRVL's 3FQ12 results ($950.4mln/$0.40) were in-line with our/consensus estimates...

Auriga is out with a research report on NetApp (NASDAQ: NTAP) and it has a Buy rating and a $40 price target on shares after it reported earnings. In a note to clients, Auriga writes, "NetApp reported a slight non-operational earnings beat but missed revenue for the second straight quarter due to...

Auriga is out with a research report on Collective Brands (NYSE: PSS) and it has a Hold rating and a $15 price target on shares. In a note to clients, Auriga writes, "We are lowering our Q3 EPS estimate ahead of PSS's Q3 earnings report. We are concerned that gross margins could be softer than...

Auriga is out with a research report on Dell (NASDAQ: DELL) and it has a Buy rating and a $25 price target on shares. In a note to clients, Auriga writes, "Dell reported another quarter of strong margins and earnings upside off of soft revenue print, consistent with recent quarters. We continue to...

A report from Auriga reiterates its Neutral rating and $42 price target on Quality Systems (NASDAQ: QSII). The report states, “We remain neutral on shares of Quality Systems (QSII, HOLD) at current valuation following the Company's Analyst event last week. The company reinforced its view that...

Auriga retains its Buy rating and $68 price target for Lululemon Athletica Inc. (NASDAQ: LULU) as the company added dance apparel in stores and on its website. Auriga comments, “While we do not believe dance specific merchandise has the same broad consumer appeal as running, we do expect the...

A report from Auriga reiterates its Buy rating and $22 price target on Cisco Systems (NASDAQ: CSCO). The report states, “We maintain our Buy Rating and $22 price rating for Cisco (CSCO) following strong results, which along with increased orders, book-to-bill and deferred revenue show potential...

A report from Auriga reiterates its Hold rating and raises its price target form $30 to $34 on Salix Pharmaceuticals (NASDAQ: SLXP). The report states, “Q3 results beat consensus on both revenue and EPS. The revenue was $146.2 million vs. consensus of $140.7 million and our estimate of $141.8...